Pioglitazone Has a Null Association with Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus

Pioglitazone shows potential benefits in inflammatory bowel disease (IBD) in preclinical studies, but its effect in humans has not been researched. We used a nationwide database of Taiwan’s National Health Insurance to investigate whether pioglitazone might affect IBD risk. We enrolled 12,763 ever u...

Descripción completa

Detalles Bibliográficos
Autor principal: Tseng, Chin-Hsiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785412/
https://www.ncbi.nlm.nih.gov/pubmed/36558989
http://dx.doi.org/10.3390/ph15121538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785412/
https://www.ncbi.nlm.nih.gov/pubmed/36558989
http://dx.doi.org/10.3390/ph15121538

Ejemplares similares